Literature DB >> 34941399

Omicron sparks a vaccine strategy debate.

Jon Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34941399     DOI： 10.1126/science.acz9879

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

1.  Patterns of Volatility Across the Spike Protein Accurately Predict the Emergence of Mutations within SARS-CoV-2 Lineages.

Authors:  Roberth A Rojas Chávez; Mohammad Fili; Changze Han; Syed A Rahman; Isaiah G L Bicar; Guiping Hu; Jishnu Das; Grant D Brown; Hillel Haim
Journal:  bioRxiv       Date:  2022-02-02

2.  Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern.

Authors:  Laura Vangeel; Winston Chiu; Steven De Jonghe; Piet Maes; Bram Slechten; Joren Raymenants; Emmanuel André; Pieter Leyssen; Johan Neyts; Dirk Jochmans
Journal:  Antiviral Res       Date:  2022-01-24       Impact factor: 5.970

3.  Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?

Authors:  Taha Menasria; Margarita Aguilera
Journal:  Microorganisms       Date:  2022-02-18

Review 4.  Turning point: A new global COVID-19 wave or a signal of the beginning of the end of the global COVID-19 pandemic?

Authors:  Kaixi Ding; Wei Jiang; Chunping Xiong; Ming Lei
Journal:  Immun Inflamm Dis       Date:  2022-04

Review 5.  A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Sang-Soo Lee
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

Review 6.  Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention.

Authors:  Ailan Xu; Bixia Hong; Fuxing Lou; Shuqi Wang; Wenye Li; Amna Shafqat; Xiaoping An; Yunwei Zhao; Lihua Song; Yigang Tong; Huahao Fan
Journal:  MedComm (2020)       Date:  2022-08-16

7.  Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid.

Authors:  Jonathan T Lee; Qingyi Yang; Alexey Gribenko; B Scott Perrin; Yuao Zhu; Rhonda Cardin; Paul A Liberator; Annaliesa S Anderson; Li Hao
Journal:  mBio       Date:  2022-07-13       Impact factor: 7.786

8.  A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.

Authors:  Jing Zhang; Zi Bo Han; Yu Liang; Xue Feng Zhang; Yu Qin Jin; Li Fang Du; Shuai Shao; Hui Wang; Jun Wei Hou; Ke Xu; Wenwen Lei; Ze Hua Lei; Zhao Ming Liu; Jin Zhang; Ya Nan Hou; Ning Liu; Fu Jie Shen; Jin Juan Wu; Xiang Zheng; Xin Yu Li; Xin Li; Wei Jin Huang; Gui Zhen Wu; Ji Guo Su; Qi Ming Li
Journal:  Elife       Date:  2022-08-25       Impact factor: 8.713

9.  Role of Omicron variant of SARS-CoV-2 in children in Germany.

Authors:  Stefan Bittmann
Journal:  World J Pediatr       Date:  2022-02-01       Impact factor: 9.186
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.